Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profile in SULF2 knockdown pancreatic tumor cells

ABSTRACT: Transcriptome profile in SULF2 knockdown pancreatic tumor cells

PROVIDER: PRJNA810844 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18156968_1.fastq.gz	Fastqsanger.gz
	SRR18156968_2.fastq.gz	Fastqsanger.gz
	SRR18156969_1.fastq.gz	Fastqsanger.gz
	SRR18156969_2.fastq.gz	Fastqsanger.gz
	SRR18156970_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Transcriptome profile in SULF2 knockdown pancreatic tumor cells

Project description:We constructed the SULF2 knockdown cell lines and its controls in CFPAC-1 cells using CRISPR-cas9 system, followed by transcriptome sequencing.

2022-03-02 | GSE197531 | GEO

Transcriptome profile of ZIP7 knockdown cells

Project description:Transcriptome profile of ZIP7 knockdown cells

| PRJNA649762 | ENA

Pancreatic Cancer HPAF/CD18 cells: Ecd knockdown vs Scrambled

Project description:Purpose: To study the expression and function of a novel cell cycle regulatory protein, human ecdysoneless (Ecd), during pancreatic cancer (PC) pathogenesis. Experimental Design: Immunohistochemical expression profiling of Ecd was done in non-neoplastic normal pancreatic tissues and pancreatic ductal adenocarcinoma lesions (from tissue microarray and Rapid Autopsy program) as well as precancerous PanIN lesions and metastatic organs. To analyze the biological significance of Ecd in PC progression, Ecd was stably knocked down in PC cell line followed by in vitro and in vivo functional assays. Results: Normal pancreatic ducts show very weak to no Ecd expression compared to significant positive expression in PC tissues (mean±SE composite score: 0.3±0.2 and 3.8±0.2 respectively, p<0.0001) as well as in PanIN precursor lesions with a progressive increase in Ecd expression with increasing dysplasia (PanIN-1 to PanIN-3). Analysis of matched primary tumors and metastases from PC patients revealed that Ecd is highly expressed in both primary pancreatic tumor and in distant metastatic sites. Further, knockdown of Ecd suppressed cell proliferation in vitro and tumorigenicity of PC cells in mice orthotopic tumors. Microarray study revealed that Ecd regulates expression of glucose transporter GLUT4 in PC cells and was subsequently shown to modulate glucose uptake, lactate production and ATP generation by PC cells. Finally, knockdown of Ecd also reduced level of pAkt, key signaling molecule known to regulate aerobic glycolysis in cancer cells. Conclusion: Ecd is a novel tumor promoting factor that is differentially expressed in pancreatic cancer and potentially regulates glucose metabolism within cancer cells. Two-condition experiment, Ecd knockdown vs Scrambled cells. Biological replicates: 3 Ecd knockdownl, 3 Scrambled, independently grown and harvested. One replicate per array

2012-08-09 | E-GEOD-39988 | biostudies-arrayexpress

TCF7L1 knockdown in pancreatic cancer

Project description:RNAi mediated depletion of TCF7L1 increases activity of a Wnt-based reporter and imparts more aggressive tumor phenotypes in vitro in pancreatic cancer cell lines that express TCF7L1. We sought to determine what changes in transcription ocurred after RNAi mediated knockdown of TCF7L1 in these cells by RNA-sequencing

2017-06-20 | GSE90926 | GEO

Transcriptome profile of peripheral blood from pancreatic ductal adenocarcinoma patients

Project description:Analysis of expression profile of peripheral blood from pancreatic ductal adenocarcinoma patients RNA expression profile of peripheral blood from pancreatic ductal adenocarcinoma patients

2015-11-04 | GSE74629 | GEO

Transcriptome alterlation by ZIC5 knockdown in pancreatic cancer cell line, PANC-1.

Project description:To examine the transcriptome alterlation caused by ZIC5 knockdown in pancreatic cancer, we performed RNA-Seq analysis.

2025-05-01 | GSE183860 | GEO

Transcriptome profile of ZIP7 knockdown cells

Project description:We analysed the transcriptome profile by RNA-seq when knockdown ZIP7 by two individual siRNAs in MDAMB231 cells.

2020-07-31 | GSE155437 | GEO

Effect of knockdown OFD1 on gene expression in pancreatic cancer cells

Project description:PARP inhibitors (PARPi) have demonstrated efficacy in treating human cancers with BRCA1 or BRCA2 gene mutations, which are present in only a small portion of breast, ovarian, prostate, and pancreatic cancers. In this study, we discovered that OFD1 is highly expressed in pancreatic cancer and is associated with a poor prognosis. Through screening an FDA-approved drug library, we found that OFD1 knockdown synergizes most effectively with PARPi for the treatment of pancreatic cancer cells. To explore the mechanism of OFD1 knockdown and PARP inhibitor-induced synthetic lethality, we knocked down OFD1 in three pancreatic cancer cell lines and performed RNA sequencing analysis of the whole genome to investigate the mechanisms underlying OFD1 inhibition and PARP inhibitor-induced synthetic lethality. In summary, our research will provide insights into the role of OFD1 in pancreatic cancer by revealing changes in the whole-genome expression profile and the underlying mechanisms.

2025-06-08 | GSE282746 | GEO

MCT4 knockdown in pancreatic cancer cells

Project description:Gene expression levels were determined with control or MCT4 knockdown pancreatic cancer cells.

2014-12-17 | GSE63231 | GEO

Transcriptome profile of fibroblast-like synoviocytes with FTO knockdown

Project description:Transcriptome profile of fibroblast-like synoviocytes with FTO knockdown

| PRJNA1007586 | ENA